Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call
Rhea-AI Summary
Strata Critical Medical (Nasdaq: SRTA) will release fourth-quarter 2025 financial results on March 3, 2026 before the market opens and will host a conference call at 8:00 am Eastern Time the same day.
The call will be hosted by Will Heyburn (Co-CEO and CFO) and Melissa Tomkiel (Co-CEO and General Counsel), include a Q&A session, and require registration to receive dial-in details and a unique PIN. An audio-only webcast will be available on the company investor relations site and a replay will remain available for one year.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
SRTA was down 1.27% while selected peers showed mixed moves, with names like UP and CAAP up and others flat. Peer momentum data also shows both up and down movers, supporting a stock-specific backdrop rather than a broad sector move.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 09 | Earnings call scheduling | Neutral | +0.8% | Announced Q3 2025 earnings release timing and conference call details. |
Prior scheduling of an earnings call with this tag saw a modest positive reaction, suggesting such announcements have been neutral to slightly positive historically.
Over recent months, Strata has combined operational updates with financing and guidance milestones. Notably, it secured a revolving credit facility of up to $30M to support acquisitions and provided detailed 2026 and medium-term financial targets, including revenue and Adjusted EBITDA goals. The last tagged conferences,earnings event on Oct 09, 2025 simply announced a Q3 2025 earnings release date and call logistics, and the stock moved about 0.8% higher, indicating these scheduling notices have not been major catalysts compared with full earnings releases or strategic updates.
Historical Comparison
Past announcements setting earnings call dates with this tag led to an average move of about 0.8%, indicating historically modest reactions to similar scheduling news.
The company has repeatedly communicated earnings release dates and call logistics, creating a consistent pattern of advance notice around quarterly reporting.
Market Pulse Summary
This announcement sets the timing and access details for Strata’s fourth quarter 2025 earnings release and conference call, continuing its pattern of advance communication around results. Investors may contextualize the upcoming report against prior milestones such as raised 2025 revenue guidance, detailed 2026 targets, and the recently established credit facility. Key elements to watch will be revenue growth, profitability trends, cash generation, and any updates relative to the medium-term financial framework shared at the 2025 Investor Day.
AI-generated analysis. Not financial advice.
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the fourth quarter ended December 31, 2025 on Tuesday, March 3, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Will Heyburn, Strata’s Co-Chief Executive Officer and Chief Financial Officer, and Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and will include a question-and-answer session for call participants.
To join the live call, please register here. Upon registration, a dial-in and unique PIN will be provided to join the call.
An audio-only webcast of the call may be accessed from the Investors section of the Company’s website at https://ir.stratacritical.com/ or by registering at the link here. A replay of the webcast will be available for one year.
About Strata Critical Medical, Inc.
Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.
Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
For more information, visit https://stratacritical.com/.
Contacts
Mathew Schneider
investors@srta.com
FAQ
When will SRTA release fourth-quarter 2025 results and hold the earnings call?
How can investors register to join the SRTA March 3, 2026 conference call?
Who will host Strata Critical Medical's Q4 2025 earnings call (SRTA)?
Will there be a live webcast and how long will the SRTA replay be available?
What should investors expect during the Strata (SRTA) March 3, 2026 call?
